Pasar al contenido principal

Hypothalamic mechanisms in the regulation of metabolism: from molecular factors to cell types

RYC2021-031225-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Fezolinetant for menopausal hot flashes and night sweats

  • González García, Ismael
  • López Pérez, Miguel A.
Fezolinetant acts on the NK3Rs expressed in kisspeptin neurons and glutamatergic MnPO neurons that receive projections from the kisspeptin neurons. This targeted mechanism allows fezolinetant to address the underlying neuroendocrine and thermoregulatory dysregulation associated with VMS, providing a focused therapeutic approach. Antagonism of the NKB effects inhibits both kisspeptin neuronal action and the activation of the MnPO neurons, ameliorating the VMS.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Defective Olfactomedin-2 connects adipocyte dysfunction to obesity

  • Lluch, Aina
  • Latorre, Jèssica
  • Espadas Villanueva, Isabel
  • Oliveras-Cañellas, Núria
  • Moreno-Navarrete, José M.
  • Caballano-Infantes, Estefanía
  • Sarker, Gitalee
  • Malvido, Nicolás F.
  • Garrido-Gil, Pablo
  • Labandeira-García, José L.
  • Nakaya, Naoki
  • Mora, Silvia
  • Chicano, Eduardo
  • López-Alcalá, Jaime
  • Malagón, María M.
  • Martín-Montalvo, Alejandro
  • Zhang, Birong
  • Zhou, You
  • Domingos, Ana I.
  • López, Miguel
  • Pörschke, Johanna
  • Gómez-Serrano, María
  • Szymanski, Witold
  • Graumann, Johannes
  • Tomarev, Stanislav I.
  • González-García, Ismael
  • Fernández-Real, José M.
  • Ortega, Francisco J.
Olfactomedin-2 (OLFM2) is a pleiotropic glycoprotein emerging as a regulator of energy homeostasis. We here show the expression of OLFM2 to be adipocyte-specific and inversely associated with obesity. OLFM2 levels increase during adipogenesis and are suppressed in inflamed adipocytes. Functionally, OLFM2 deficiency impairs adipocyte differentiation, while its over-production enhances the adipogenic transformation of fat cell progenitors. Loss and gain of function experiments revealed that OLFM2 modulates key metabolic and structural pathways, including PPAR signaling, citrate cycle, fatty acid degradation, axon guidance and focal adhesion in 3T3 cell lines and primary human adipocytes. On the molecular level, OLFM2 deficiency in differentiated adipocytes predominantly downregulates genes involved in cell cycle. Extending these findings in vivo, both whole-body Olfm2 knockout and adipose-specific Olfm2 depletion in mice resulted in impaired adipose cell cycle gene expression, with the latter also displaying fat mass accretion and metabolic dysfunction. Collectively, our results underscore a critical role for OLFM2 in adipocyte biology, and support a causative link between reduced adipose OLFM2 and the pathophysiology of obesity., This study has been funded by the Instituto de Salud Carlos III (ISCIII), through the projects CP19/00109, PI18/00550, and PI21/00074 (to F.J.O.), the Ministerio de Ciencia e Innovación (PID2022-141115NA-I00 to I.G.-G.; PID2022-142951OB-I00 to S.M.; PID2021-128145NB-I00 and PDC2022-133958-I00, to M.L.), and the Xunta de Galicia (ED431C 2024/10 and ED431F 2024/14, to I.G.-G.), also co-founded by the European Union and the Fondo Europeo de Desarrollo Regional (FEDER). F.J.O. (MS19/00109) is recipient of the Miguel Servet scheme (ISCIII), A.L. (FI19/00045) is recipient of a Contrato Predoctoral de Formación en Investigación en Salud (PFIS, ISCIII), I.G.-G. is supported by a Ramón y Cajal award (RYC2021-031225-I), and N.F.M. is recipient of a Contrato Predoctoral para la Formación de Doctores (PREP2022-000775), Ministerio de Ciencia, Innovación y Universidades, Gobierno de España (ES). N.N. and S.I.T. were supported by the Intramural Research Programs of the National Eye Institute, NIH. The authors thank the CERCA and PERIS programmes (Generalitat de Catalunya) for financial and institutional support, and are indebted to the participants of the FATBANK platform, promoted by the Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y la Nutrición (CIBEROBN, ISCIII) and the Institut d’Investigació Biomèdica de Girona (IDIBGI) Biobank (Biobanc IDIBGI, B.0000872), integrated in the Spanish National Biobanks Network, for their collaboration and coordination. We would like to thank the Animal Facility of the Barcelona Science Park and its staff for the technical assistance provided in carrying out the tasks related to the work with animals. The authors are also indebted to the IMIM Microarray Analysis Service (Hospital del Mar Medical Research Institute, Barcelona, Spain) for technical guidance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism

  • Fernández-González, Iara
  • Freire-Agulleiro, Oscar
  • Ferreira, Vitor
  • Silveira-Loureiro, María
  • Rial-Pensado, Eva
  • Garrido-Gil, Pablo
  • Martínez, Gloria
  • Rada, Patricia
  • Labandeira-Garcia, Jose Luis
  • Mittag, Jens
  • González-García, Ismael
  • Diéguez, Carlos
  • Nogueiras, Rubén
  • Valverde, Ángela M.
  • Davis, Roger J.
  • Sabio, Guadalupe
  • Barca-Mayo, Olga
  • López, Miguel
[Objective] Hypothalamic energy sensors, such as AMP-activated protein kinase (AMPK), and stress sensors, such as c-Jun N-terminal kinase 1 (JNK1, also known as MAPK8) modulate whole body energy balance. While the role of AMPK in steroidogenic factor 1 (SF1) neurons of the VMH has been investigated, the relevance of JNK1 in this neuronal population has not been addressed. Here, we investigated the involvement of JNK1 SF1 on energy homeostasis., [Methods] We generated mice bearing conditional JNK1 disruption through Mapk8 gene deletion in SF1 neurons (Sf1Cre/Jnk1fl/fl). Complete metabolic phenotyping, fasting/refeeding and cold challenges, as well as the central response to triiodothyronine (T3) on brown adipose tissue (BAT) thermogenesis and hepatic lipid metabolism were carried out., [Results] Sf1Cre/Jnk1fl/fl mice displayed decreased body weight, improved glucose tolerance, and reduced hepatic lipid levels. However, Sf1Cre/Jnk1fl/fl did not properly defend their temperature upon cold exposure. While central administration of T3 elicited feeding independent weight loss in both wildtype (Jnk1fl/fl) and SF1Cre/Jnk1fl/fl mice, it did not promote hepatic lipid accretion in null animals., [Conclusions] Our data demonstrated for the first time that JNK1 in SF1 neurons is necessary for the regulation of hepatic lipid metabolism, cold adaptation and central T3 actions., The research leading to these results has received funding from the Xunta de Galicia (IG-G: ED431F 2024/14; IG-G and RN ED431C 2024/10; RN: 2016-PG057; OB-M: ED431F 2020/009 and ED431C 2023/28); Ministerio de Ciencia e Innovación co-funded by the FEDER Program of EU (IG-G: PID2022-141115NA-I00; CD: PID2020-116628 GB-I00; RN: RTI2018-099413-B-I00 and RED2018-102379-T; AM-V; PID2021-122766OB-100; GS: PID2019-104399RB-I00; PMP21/00057; PDC2021-121147-I00 IMPACT-202; OB-M: PID2019-109556RB-I00; PID2022-138436OB-I00; ML: PID2021-128145NB-I00 and PDC2022-133958-I00); European Research Council (RN: ERC Synergy Grant-2019-WATCH- 810331); “la Caixa” Foundation (ID 100010434), (ML: LCF/PR/HR19/52160022 and LCF/PR/HR20/52400013); Fundación AECC (GS: PROYE19047SABI; ML: PRYGN234908LOPE). IG-G and OB-M are supported by Ramón y Cajal Awards (IG-G: RYC2021-031225-I; OB-M: RYC2018-026293-I) from the Ministerio de Ciencia e Innovación of Spain. OF-A was supported by a fellowship from Xunta de Galicia (ED481A-2019/026). CiMUS was supported by the Xunta de Galicia (2020–2023, ED431G/05). CIBER de Fisiopatología de la Obesidad y Nutrición, CIBER de Diabetes y Enfermedades Metabólicas Asociadas and CIBER de Enfermedades Neurodegenerativas are initiatives of ISCIII., Peer reviewed